Public Sector Growth VA contract renewal demonstrates ongoing public sector demand for at home musculoskeletal therapies. ZetrOZ's sam wearable ultrasound aligns with veteran care goals for accessible soft tissue rehabilitation. There is an opportunity to expand into additional federal channels and broader hospital networks through public procurement programs, leveraging ISO 13485 quality and made in the USA messaging.

Clinical Partnerships Arthritis Foundation partnership shows traction in knee osteoarthritis and patient education channels. This creates opportunities to embed sam in physical therapy clinics and sports medicine practices, and to run pilots with payers. Leverage the Pathways Conference exposure to build relationships with rheumatology and orthopedics networks.

Product Innovation Launch of sam 3.0 multi hour continuous ultrasound wearable signals ongoing R and D momentum and competitive differentiation. Target sales to professional sports teams, athletic trainers, and durable medical equipment distributors serving home based rehab. Emphasize remote patient support and integration with telehealth care pathways.

Regulatory Readiness ISO 13485 certification positions ZetrOZ for hospital and payer adoption. This can be used to pursue larger health system contracts and partnerships with medical device distributors that require regulatory compliance. Robust regulatory documentation and quality systems support scalable manufacturing and audits.

Channel Opportunities Current revenue range and mid sized employee base indicate a fertile mid market entry path in government, clinics, and patient organizations. The competitive landscape includes players like Breg, Hyperice, and Thuasne, but ZetrOZ differentiates with home use, clinical validation, and government partnerships. Target channels include DME providers, physical therapy clinics, sports medicine networks, and veteran care programs to accelerate adoption.